Doctors in this week’s British Medical Journal are warning about the use of high-powered handheld laser pointers after treating a young patient with serious eye injuries.
Doctors in this week’s British Medical Journal are warning about the use of high-powered handheld laser pointers after treating a young patient with serious eye injuries.
Dr Kimia Ziahosseini and colleagues from the Royal Liverpool University Hospital and Manchester Royal Eye Hospital describe the case of a teenager who presented with central scotomas (dark spots) after he bought a green diode laser pointer over the Internet and shone the laser beam into his eyes while playing with it.
His visual acuity was poor and tests revealed burns to the surface of the eye and disturbances to the retina, the light-sensitive tissue at the back of the eye. Two months later, his visual acuity improved but some retinal damage remained.
The authors warn that, although lasers may cause only a transient afterimage, they can lead to permanent retinal damage and visual loss in later years.
The U.K. Health Protection Agency has received no previous reports of such injury from laser pointers, they write. It advises that laser products sold to the general public for use as laser pointers should be restricted to devices with laser power less than 1 mW, in accordance with the British Standard, and be accompanied by sufficient information on their safe operation.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.